Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infectionsChao Zhang, Zhong Huang, Chenjian Gu et al.|Nature Communications|2021Cited by 108
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infectionJinkai Zang, Zhong Huang, Yuanfei Zhu et al.|Cell Discovery|2021Cited by 70